Welcome to the Hawaii Chapter of the American College of Cardiology


2026 Conference
Click here to learn about our annual Chapter meeting April 25, 2026
Click here to download the flyer

ACC Live Courses
For a listing of all ACC Live Courses please visit: https://www.acc.org/education-and-meetings/meetings


RSS feed: Latest in Cardiology from ACC.org Latest in Cardiology from ACC.org

  • Black Adults in Disadvantaged Neighborhoods Less Likely to Be Diagnosed With AFib
    Among individuals living in more disadvantaged neighborhoods, non-Hispanic Black adults were less likely to be diagnosed with atrial fibrillation (AFib) than non-Hispanic White adults, according to a cohort study of Medicare Advantage and commercially insured individuals published Oct. 23 in JAMA Network Open.
  • Can Echocardiographic Evaluation of Severe MR Be More Efficient?
    Certain criteria from the American Society of Echocardiography (ASE) guidelines, such as pulmonary vein systolic reversal and left ventricle (LV) remodeling parameters, are "highly specific" for diagnosing severe mitral regurgitation (MR) even when less than four criteria are present, according to a recent study published in JACC: Cardiovascular Imaging.
  • Frailty and Sarcopenia in HFpEF: Considerations for GLP1RAs
    Heart failure with preserved ejection fraction (HFpEF) affects an estimated 3 million people in the United States and up to 32 million worldwide, with an estimated lifetime risk of heart failure (HF) exceeding 10% at 45 years of age in both men and women.
  • CAUGHT-CAD Analysis: Statin Therapy and Plaque Passivation
    Statin treatment in asymptomatic, intermediate-risk individuals was associated with plaque passivation, a shift toward higher density calcium within coronary plaques, with greater increases in high- and very high-density calcium among patients achieving an LDL-C reduction ≥30%...
  • JACC State-of-the-Art Review Supports hs-cTn Classification in Clinical Practice
    In a JACC State-of-the-Art Review published Oct. 28, Michail Spanos, MD, and James L. Januzzi, MD, FACC, examine the interpretation of high-sensitivity cardiac troponin (hs-cTn) levels, including differences between assays, guideline-endorsed serial testing...